Antiobesity medications are linked to significant weight regain at 8 weeks after drug discontinuation compared with control group.

The FDA, HHS, and USDA published a joint Request for Information to establish a federally recognized definition of ultra-processed foods.

Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.

This in-depth feature explores the challenges and controversies surrounding the diagnosis and management of PANDAS.

In a review and meta-analysis, serious spinal pathologies accounted for 3% of cases of LBP, with higher rates in complex care settings.

Charissa van Zwol-Janssens, M.D., from the Erasmus Medical Center in Rotterdam, Netherlands, and colleagues conducted an exploratory cross-sectional observational study to examine associations between ...

Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is effective in adults with active Crohn disease.

Moderate-to-vigorous physical activity for at least 150 minutes per week reduces mortality in people with diabetes.

The Health Resources and Services Administration wants to strengthen national safeguards and monitoring to improve organ donation safety.

The prevalence of pediatric obesity, especially extremely severe obesity, increased from 2008 to 2023 in the US.

A growing number of women with chronic inflammatory diseases are continuing to use TNF inhibitors throughout pregnancy.

Models based on noninvasive testing, features, and clinical symptoms show high accuracy in identifying IBD in children.